Clinical trials
Multiple Sclerosis, Chronic Progressive trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Recruiting | 4 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 5 |
| Novartis Pharmaceuticals | 5 |
| Sanofi | 3 |
| Eli Lilly and Company | 2 |
| Genzyme, a Sanofi Company | 2 |
| AB Science | 1 |
| Bayer | 1 |
| Biogen | 1 |
| Friedemann Paul | 1 |
| Genentech, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 30 |
| Multiple Sclerosis | 14 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| COVID-19 | 1 |
| Carcinoma in Situ | 1 |
| Disease Progression | 1 |
| Fatigue | 1 |
| Fatigue Syndrome, Chronic | 1 |
| Neoplasm Metastasis | 1 |
| Sleep Wake Disorders | 1 |
Trials
Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.